newsfilter
← Latest News
GlobeNewswire·

Celyad Oncology Presents Preclinical Data on Allogeneic CAR T Therapy Program and Highlights KEYNOTE-B79 Clinical Trial Design at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

Preclinical data support armoring NKG2D CAR T cells with IL-18 to drive improved anti-tumor activity of the product candidate Development continues for second-generation multiplexing shRNA scaffold for novel non-gene edited CAR T candidates with desire